|
1
|
Shahmoradi Z, Najafian J, Naeini FF and
Fahimipour F: Vitiligo and autoantibodies of celiac disease. Int J
Prev Med. 4:200–203. 2013.PubMed/NCBI
|
|
2
|
Dertlioğlu SB, Oğuz H, Çiçek D and Yücel
H: Prevalence of glaucoma in patients with vitiligo. Cutis.
97:E21–E25. 2016.PubMed/NCBI
|
|
3
|
Yaghoobi R, Omidian M and Bagherani N:
Vitiligo: A review of the published work. J Dermatol. 38:419–431.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krüger C and Schallreuter KU: A review of
the worldwide prevalence of vitiligo in children/adolescents and
adults. Int J Dermatol. 51:1206–1212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whitton M, Pinart M, Batchelor JM,
Leonardi-Bee J, Gonzalez U, Jiyad Z, Eleftheriadou V and Ezzedine
K: Evidence-based management of vitiligo: Summary of a Cochrane
systematic review. Br J Dermatol. 174:962–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Malhotra N and Dytoc M: The pathogenesis
of vitiligo. J Cutan Med Surg. 17:153–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mohammed GF, Gomaa AH and Al-Dhubaibi MS:
Highlights in pathogenesis of vitiligo. World J Clin Cases.
3:221–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ezzedine K, Eleftheriadou V, Whitton M and
van Geel N: Vitiligo. Lancet. 386:74–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zuo RC, Naik HB, Steinberg SM, Baird K,
Mitchell SA, Kuzmina Z, Pavletic SZ and Cowen EW: Risk factors and
characterization of vitiligo and alopecia areata in patients with
chronic graft-vs-host disease. JAMA Dermatol. 151:23–32. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Whitton ME, Ashcroft DM and González U:
Therapeutic interventions for vitiligo. J Am Acad Dermatol.
59:713–717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Whitton ME, Pinart M, Batchelor J,
Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V and Ezzedine
K: Interventions for vitiligo. Cochrane Database Syst Rev.
CD003263:2015.
|
|
12
|
Adauwiyah J and Suraiya HH: A
retrospective study of narrowband-UVB phototherapy for treatment of
vitiligo in Malaysian patients. Med J Malaysia. 65:297–299.
2010.PubMed/NCBI
|
|
13
|
Hamzavi IH, Lim HW and Syed ZU:
Ultraviolet-based therapy for vitiligo: What's new? Indian J
Dermatol Venereol Leprol. 78:42–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shenoi SD and Prabhu S: Indian Association
of Dermatologists V and Leprologists: Photochemotherapy (PUVA) in
psoriasis and vitiligo. Indian J Dermatol Venereol Leprol.
80:497–504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spencer JM, Nossa R and Ajmeri J:
Treatment of vitiligo with the 308-nm excimer laser: A pilot study.
J Am Acad Dermatol. 46:727–731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esposito M, Soda R, Costanzo A and
Chimenti S: Treatment of vitiligo with the 308 nm excimer laser.
Clin Exp Dermatol. 29:133–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang YS, Cho HR, Ryou JH and Lee MH:
Clinical study of repigmentation patterns with either narrow-band
ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean
vitiligo patients. Int J Dermatol. 49:317–323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang XY, He YL, Dong J, Xu JZ and Wang J:
Clinical efficacy of a 308 nm excimer laser in the treatment of
vitiligo. Photodermatol Photoimmunol Photomed. 26:138–142. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Le Duff F, Fontas E, Giacchero D, Sillard
L, Lacour JP, Ortonne JP and Passeron T: 308-nm excimer lamp vs.
308-nm excimer laser for treating vitiligo: A randomized study. Br
J Dermatol. 163:188–192. 2010.
|
|
20
|
Do JE, Shin JY, Kim DY, Hann SK and Oh SH:
The effect of 308 nm excimer laser on segmental vitiligo: A
retrospective study of 80 patients with segmental vitiligo.
Photodermatol Photoimmunol Photomed. 27:147–151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Travis LB, Weinberg JM and Silverberg NB:
Successful treatment of vitiligo with 0.1% tacrolimus ointment.
Arch Dermatol. 139:571–574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matin M, Latifi S, Zoufan N, Koushki D,
Mirjafari Daryasari SA and Rahdari F: The effectiveness of excimer
laser on vitiligo treatment in comparison with a combination
therapy of Excimer laser and tacrolimus in an Iranian population. J
Cosmet Laser Ther. 16:241–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park OJ, Park GH, Choi JR, Jung HJ, Oh ES,
Choi JH, Lee MW and Chang SE: A combination of excimer laser
treatment and topical tacrolimus is more effective in treating
vitiligo than either therapy alone for the initial 6 months, but
not thereafter. Clin Exp Dermatol. 41:236–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oh TS, Lee O, Kim JE, Son SW and Oh CH:
Quantitative method for measuring therapeutic efficacy of the 308
nm excimer laser for vitiligo. Skin Res Technol. 18:347–355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baldi A, Quartulli M, Murace R, Dragonetti
E, Manganaro M, Guerra O and Bizzi S: Automated dermoscopy image
analysis of pigmented skin lesions. Cancers (Basel). 2:262–273.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Celebi ME, Mendonca T and Marques JS:
Dermoscopy Image Analysis. 141. 1st. Boca Raton, Florida, USA: pp.
200–210. 2015, PubMed/NCBI
|
|
27
|
Soyer HP, Argenziano G, Zalaudek I, Corona
R, Sera F, Talamini R, Barbato F, Baroni A, Cicale L, Di Stefani A,
et al: Three-point checklist of dermoscopy. A new screening method
for early detection of melanoma. Dermatology. 208:27–31. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiaolan D, Juan Du and Jianzhong Z: The
epidemiology and treatment of vitiligo: A chinese perspective. J
Pigmentary Disord. 1:62014.
|
|
29
|
Awad SS: Depigmentation during vitiligo
activity spares epithelial grafted areas. J Cosmet Dermatol.
15:383–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Laddha NC, Dwivedi M, Mansuri MS, Singh M,
Gani AR, Yeola AP, Panchal VN, Khan F, Dave DJ, Patel A, et al:
Role of oxidative stress and autoimmunity in onset and progression
of vitiligo. Exp Dermatol. 23:352–353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim MS, Cho EB, Park EJ, Kim KH and Kim
KJ: Effect of excimer laser treatment on vitiliginous areas with
leukotrichia after confirmation by dermoscopy. Int J Dermatol.
55:886–892. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thatte SS, Dongre AM and Khopkar US:
‘Reversed pigmentary network pattern’ in evolving lesions of
vitiligo. Indian Dermatol Online J. 6:222–223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thatte SS and Khopkar US: The utility of
dermoscopy in the diagnosis of evolving lesions of vitiligo. Indian
J Dermatol Venereol Leprol. 80:505–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chandrashekar L: Dermatoscopy of blue
vitiligo. Clin Exp Dermatol. 34:e125–e126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meng RS, Zhao G, Cai RK, Meng X and Jiang
ZG: Application of polarized light dermoscopy in the early
diagnosis of vitiligo and its differential diagnosis from other
depigmented diseases. Zhonghua Pi Fu Ke Za Zhi. 810–813. 2009.
|
|
36
|
Song LX, Yan-Zhu XU and Zhang SF:
Expression levels of T-lymphocyte subsets in peripheral blood of
patients with vitiligo in different staging. Lin Chuang Wu Zhen Wu
Zhi. 49:931–951. 2013.(In Chinese).
|
|
37
|
Cather JC, Abramovits W and Menter A:
Cyclosporine and tacrolimus in dermatology. Dermatol Clin.
19:119–137, ix. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang HL and Huang XY: 308 nm excimer laser
triggers two different apoptotic pathways of T lymphocytes. J Clin
Dermatol. 37:639–641. 2008.
|
|
39
|
Steitz J, Wenzel J, Gaffal E and Tüting T:
Initiation and regulation of CD8+T cells recognizing melanocytic
antigens in the epidermis: Implications for the pathophysiology of
vitiligo. Eur J Cell Biol. 83:797–803. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang HY, le Duff F, Passeron T, Lacour JP,
Ortonne JP and Bahadoran P: A noninvasive technique, reflectance
confocal microscopy, for the characterization of melanocyte loss in
untreated and treated vitiligo lesions. J Am Acad Dermatol.
63:e97–e100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Silverberg NB, Lin P, Travis L, Farley-Li
J, Mancini AJ, Wagner AM, Chamlin SL and Paller AS: Tacrolimus
ointment promotes repigmentation of vitiligo in children: A review
of 57 cases. J Am Acad Dermatol. 51:760–766. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Majid I: Does topical tacrolimus ointment
enhance the efficacy of narrowband ultraviolet B therapy in
vitiligo? A left-right comparison study. Photodermatol Photoimmunol
Photomed. 26:230–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nordal EJ, Guleng GE and Rönnevig JR:
Treatment of vitiligo with narrowband-UVB (TL01) combined with
tacrolimus ointment (0.1%) vs. placebo ointment, a randomized
right/left double-blind comparative study. J Eur Acad Dermatol
Venereol. 25:1440–1443. 2011. View Article : Google Scholar : PubMed/NCBI
|
